Last $15.05 USD
Change Today +0.58 / 4.01%
Volume 1.0M
IRWD On Other Exchanges
Symbol
Exchange
NASDAQ GS
Berlin
As of 8:10 PM 07/23/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

I. C. Wang Ph.D.

Scientific Advisor, Ironwood Pharmaceuticals, Inc.
AgeTotal Calculated CompensationThis person is connected to 54 board members in 6 different organizations across 10 different industries.

See Board Relationships
77--

Background*

Dr. I. C. Wang, known as Daniel, Ph.D. serves as Scientific Advisor of Ironwood Pharmaceuticals Inc. (formerly Microbia, Inc.). Dr. Wang founded the Biotechnology Process Engineering Center Initiative. He serves as Chief Financial Officer and Senior Vice President of Maxygen, Inc. He served as Chairman of the Board of PerSeptive Biosystems Inc. from April 1991 to March 1993. He serves as a Director of the Biotechnology Process Engineering Center, A-Bio Pharma Pte Ltd. ...

Read Full Background

Corporate Headquarters*

301 Binney Street
Cambridge, Massachusetts 02142

United States

Phone: 617-621-7722
Fax: 617-494-0480

Board Members Memberships*

Director
Director
1988-Present
Director
1997-N/A
Former Director
2000-N/A
Former Director and Member of Nominating & Governance Committee
2006-N/A
Former Director

Education*

MS
Massachusetts Institute of Technology
BS
Massachusetts Institute of Technology
PhD
The University of Pennsylvania
Doctorate
Hong Kong University Of Science And Technology

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

There is no Total Compensation data available.
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
IRWD:US $15.05 USD +0.58

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Rick E. Winningham Chairman, Chief Executive Officer, Member of Stock Option Committee and Member of Science & Technology Advisory Committee
Theravance Inc.
$986.9K
Howard W. Robin Chief Executive Officer, President and Director
Nektar Therapeutics
$831.2K
Mark R. Baker J.D.Chief Executive Officer, Director and Member of Science & Strategy Committee
Progenics Pharmaceuticals, Inc.
$535.6K
Peter S. Greenleaf Chief Executive Officer, Director, Member of Commercialization Committee and Member of Science & Technology Committee
Sucampo Pharmaceuticals, Inc.
--
A. J. Kazimi MBAFounder, Chairman, Chief Executive Officer and President
Cumberland Pharmaceuticals, Inc.
$620.0K
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact IRONWOOD PHARMACEUTICALS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.